These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 23744571)

  • 21. Intravenous Thrombolysis in Unknown-Onset Stroke: Results From the Safe Implementation of Treatment in Stroke-International Stroke Thrombolysis Registry.
    Dorado L; Ahmed N; Thomalla G; Lozano M; Malojcic B; Wani M; Millán M; Tomek A; Dávalos A
    Stroke; 2017 Mar; 48(3):720-725. PubMed ID: 28174326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Remote or extraischemic intracerebral hemorrhage--an uncommon complication of stroke thrombolysis: results from the safe implementation of treatments in stroke-international stroke thrombolysis register.
    Mazya MV; Ahmed N; Ford GA; Hobohm C; Mikulik R; Nunes AP; Wahlgren N;
    Stroke; 2014 Jun; 45(6):1657-63. PubMed ID: 24788971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External validation of the SEDAN score for prediction of intracerebral hemorrhage in stroke thrombolysis.
    Mazya MV; Bovi P; Castillo J; Jatuzis D; Kobayashi A; Wahlgren N; Ahmed N
    Stroke; 2013 Jun; 44(6):1595-600. PubMed ID: 23632975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient outcomes from symptomatic intracerebral hemorrhage after stroke thrombolysis.
    Strbian D; Sairanen T; Meretoja A; Pitkäniemi J; Putaala J; Salonen O; Silvennoinen H; Kaste M; Tatlisumak T;
    Neurology; 2011 Jul; 77(4):341-8. PubMed ID: 21715707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of Endovascular Thrombectomy for Acute Ischaemic Stroke in Anticoagulated Patients Ineligible for Intravenous Thrombolysis.
    Wong JWP; Churilov L; Dowling R; Mitchell P; Bush S; Kanesan L; Yan B
    Cerebrovasc Dis; 2018; 46(5-6):193-199. PubMed ID: 30384367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IV thrombolysis in very severe and severe ischemic stroke: Results from the SITS-ISTR Registry.
    Mazya MV; Lees KR; Collas D; Rand VM; Mikulik R; Toni D; Wahlgren N; Ahmed N
    Neurology; 2015 Dec; 85(24):2098-106. PubMed ID: 26546630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety of Endovascular Intervention for Stroke on Therapeutic Anticoagulation: Multicenter Cohort Study and Meta-Analysis.
    Kurowski D; Jonczak K; Shah Q; Yaghi S; Marshall RS; Ahmad H; McKinney J; Torres J; Ishida K; Cucchiara B
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1104-1109. PubMed ID: 28110890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China).
    Fan Y; Liao X; Pan Y; Dong K; Wang Y; Wang Y;
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):220-226. PubMed ID: 30366863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
    Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperdense middle cerebral artery sign is associated with increased risk of hemorrhagic transformation after intravenous thrombolysis for patients with acute ischaemic stroke.
    Zou M; Churilov L; He A; Campbell B; Davis SM; Yan B
    J Clin Neurosci; 2013 Jul; 20(7):984-7. PubMed ID: 23664409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC; Gupta R; Smith WS; Kamel H; Faigeles BS; Cullen SP; Rao VA; Bath PM; Wahlgren N; Ahmed N; Donnan GA;
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Outcomes of Intravenous tPA in Acute Ischemic Stroke Patients With Prior Stroke Within 3 Months: Findings From Get With The Guidelines-Stroke.
    Shah S; Liang L; Kosinski A; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Feng W; Peterson ED; Xian Y
    Circ Cardiovasc Qual Outcomes; 2020 Jan; 13(1):e006031. PubMed ID: 31903770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW; Zhang XJ; Cheng LS; Li GY; Zhang LJ; Ji KX; Zhao Q; Bai Y
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous thrombolysis in stroke mimics: results from the SITS International Stroke Thrombolysis Register.
    Keselman B; Cooray C; Vanhooren G; Bassi P; Consoli D; Nichelli P; Peeters A; Sanak D; Zini A; Wahlgren N; Ahmed N; Mazya MV
    Eur J Neurol; 2019 Aug; 26(8):1091-1097. PubMed ID: 30793434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study.
    Rubiera M; Ribo M; Pagola J; Coscojuela P; Rodriguez-Luna D; Maisterra O; Ibarra B; Piñeiro S; Meler P; Romero FJ; Alvarez-Sabin J; Molina CA
    Stroke; 2011 Apr; 42(4):993-7. PubMed ID: 21372307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Organizational changes aiming to reduce iv tPA door-to-needle time.
    Thortveit ET; Bøe MG; Ljøstad U; Mygland A; Tveiten A
    Acta Neurol Scand; 2014 Oct; 130(4):248-52. PubMed ID: 24256431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Belgian experience with intravenous thrombolysis for acute ischemic stroke.
    Vanacker P; Thijs V; Peeters A; Bruneel B; Laloux P; Druwé P; De Deyn P; Ahmed N; Wahlgren N; Vanhooren G;
    Acta Neurol Belg; 2010 Jun; 110(2):157-62. PubMed ID: 20873445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.